⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31340495 | 0.97 | — | — | |
| SCHEMBL1829299 | 0.82 | — | — | |
| SCHEMBL1782650 | 0.67 | — | — | |
| SCHEMBL38003 | 0.67 | — | — | |
| Thiazolidine SCHEMBL6425125 | 0.63 | — | — | |
| SCHEMBL1834157 | 0.62 | — | — | |
| SCHEMBL3339679 | 0.59 | — | — | |
| SCHEMBL1829036 | 0.59 | — | — | |
| SCHEMBL108935 | 0.58 | — | — | |
| SCHEMBL15387767 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 473 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4663182-A2 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPOXIC INJURY, ISCHAEMIA-REPERFUSION INJURY AND INFLAMMATION, CELL PROTECTION AGENT FOR TRANSPLANTATION, AND BIO-PRESERVATION AGENT | Scent Science International Inc. (JP) | 2025-12-17 | — | — | EP | claimed |
| CN-119345196-A | Preventive or therapeutic agent for hypoxia disorder, ischemia reperfusion disorder or inflammation, cytoprotective agent for transplantation, and organism preservative | 脑科学香料株式会社 | 2025-01-24 | — | — | CN | claimed |
| CN-119112885-A | Preventive or therapeutic agent for hypoxia disorder, ischemia reperfusion disorder or inflammation, cytoprotective agent for transplantation, and organism preservative | 脑科学香料株式会社 | 2024-12-13 | — | — | CN | claimed |
| CN-119015277-A | Preventive or therapeutic agent for hypoxia disorder, ischemia reperfusion disorder or inflammation, cytoprotective agent for transplantation, and organism preservative | 脑科学香料株式会社 | 2024-11-26 | — | — | CN | claimed |
| US-20240382497-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPOXIC INJURY, ISCHAEMIA-REPERFUSION INJURY AND INFLAMMATION, CELL PROTECTION AGENT FOR TRANSPLANTATION, AND BIO-PRESERVATION AGENT | SCENT SCIENCE INTERNATIONAL INC. (JP) | 2024-11-21 | — | — | US | claimed |
| US-20230293542-A1 | SENSORY STIMULATING PSYCHOTROPIC DRUG | KANSAI MEDICAL UNIVERSITY (JP) | 2023-09-21 | — | — | US | claimed |
| CN-116437916-A | Sensory stimulation mental medicine | 学校法人关西医科大学 | 2023-07-14 | — | — | CN | claimed |
| EP-4190325-A1 | SENSORY STIMULATING PSYCHOTROPIC DRUG | Kansai Medical University (JP) | 2023-06-07 | — | — | EP | claimed |
| US-20230149417-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR HYPOXIC INJURY, ISCHAEMIA-REPERFUSION INJURY AND INFLAMMATION, CELL PROTECTION AGENT FOR TRANSPLANTATION, AND BIO-PRESERVATION AGENT | SCENT SCIENCE INTERNATIONAL INC. (JP) | 2023-05-18 | — | — | US | claimed |
| US-20230149420-A1 | ANTI-INFLAMMATORY IMMUNOENHANCER | SCENT SCIENCE INTERNATIONAL INC. (JP) | 2023-05-18 | — | — | US | claimed |
| EP-1551811-A1 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS | Amgen Inc. (US) | 2005-07-13 | — | — | EP | claimed |
| EP-1542692-A1 | AMINO-PYRIDINE, -PYRIDINE AND PYRIDAZINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN | Amgen Inc. (US) | 2005-06-22 | — | — | EP | claimed |
| EP-1463714-A2 | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS | Amgen Inc. (US) | 2004-10-06 | — | — | EP | claimed |
| US-20040152690-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN INC. | 2004-08-05 | — | — | US | claimed |
| US-20040082780-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN, INC. | 2004-04-29 | — | — | US | claimed |
| WO-2004035549-A1 | BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS | AMGEN INC. (US) | 2004-04-29 | — | — | WO | claimed |
| US-20040038969-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN, INC. | 2004-02-26 | — | — | US | claimed |
| WO-2003099284-A1 | AMINO-PYRIDINE, -PYRIDINE AND PYRIDAZINE DERIVATIVES FOR USE AS VANILLOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN | AMGEN INC. (US) | 2003-12-04 | — | — | WO | claimed |
| US-20030195201-A1 | Vanilloid receptor ligands and their use in treatments | AMGEN INC. | 2003-10-16 | — | — | US | claimed |
| WO-2003049702-A2 | VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS | AMGEN INC. (US) | 2003-06-19 | — | — | WO | claimed |